Talaris Therapeutics to Participate at Two Upcoming Investor Conferences

Rhea-AI Summary

Talaris Therapeutics, Inc. (Nasdaq: TALS) announced the participation of its senior management team in two upcoming investor conferences. The first is the Morgan Stanley Healthcare Corporate Access Day on March 29, 2022, at the Boston Harbor Hotel, featuring 1x1 meetings. The second is a Guggenheim Virtual Genomic Medicines and Rare Disease Day on March 31, 2022, with a fireside chat at 3:00 p.m. ET. A live webcast of the Guggenheim event will be available on Talaris' website, with a replay accessible afterward. Talaris focuses on cell therapies for organ transplantation and immune disorders.

BOSTON and LOUISVILLE, Ky., March 22, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune disorders, today announced that members of its senior management team will participate at the following investor conferences:

Morgan Stanley Healthcare Corporate Access Day
Date: Tuesday, March 29, 2022
Location: Boston Harbor Hotel, Boston, MA
1x1 meetings only

Guggenheim Virtual Genomic Medicines and Rare Disease Day
Fireside chat date: Thursday, March 31, 2022
Fireside chat time: 3:00 p.m. ET

A live webcast of the presentation at the Guggenheim Genomic Medicines and Rare Disease Day will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, a replay of the event can be found on the Talaris website.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com 
(617) 903-8783

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com 
(339) 970-2843

FAQ

When is the Morgan Stanley Healthcare Corporate Access Day for Talaris Therapeutics?

The Morgan Stanley Healthcare Corporate Access Day will be held on March 29, 2022.

What time is the fireside chat at the Guggenheim Virtual Genomic Medicines and Rare Disease Day for TALS?

The fireside chat is scheduled for March 31, 2022, at 3:00 p.m. ET.

Where will the Morgan Stanley Healthcare Corporate Access Day take place?

The event will take place at the Boston Harbor Hotel in Boston, MA.

How can I access the live webcast of the Guggenheim event for Talaris Therapeutics?

The live webcast can be accessed on the investors section of the Talaris website.

What does Talaris Therapeutics focus on?

Talaris Therapeutics develops cell therapies aimed at transforming solid organ transplantation and treating severe immune and blood disorders.